Page last updated: 2024-10-23

bisbenzimidazole and Autosomal Recessive Emery-Dreifuss Muscular Dystrophy

bisbenzimidazole has been researched along with Autosomal Recessive Emery-Dreifuss Muscular Dystrophy in 1 studies

Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kandert, S1
Wehnert, M1
Müller, CR1
Buendia, B1
Dabauvalle, MC1

Other Studies

1 other study available for bisbenzimidazole and Autosomal Recessive Emery-Dreifuss Muscular Dystrophy

ArticleYear
Impaired nuclear functions lead to increased senescence and inefficient differentiation in human myoblasts with a dominant p.R545C mutation in the LMNA gene.
    European journal of cell biology, 2009, Volume: 88, Issue:10

    Topics: Aging; Amino Acid Substitution; Antibodies; Bisbenzimidazole; Carbocyanines; Case-Control Studies; C

2009